Steven R. Grossman named division chair of hematology, oncology and palliative care
Steven R. Grossman, M.D., Ph.D., has been named division chair in the Division of Hematology, Oncology and Palliative Care in the Virginia Commonwealth University School of Medicine and at VCU Massey Cancer Center, effective July 1, 2011. Grossman, an internationally recognized expert in gastrointestinal cancers, comes to VCU from the University of Massachusetts Medical School in Worcester, Mass., where he is currently an associate professor in the Departments of Cancer Biology and Medicine. He is also medical director of the Simonds-Sinon Regional Cancer Center and co-director of the Center for Gastrointestinal Oncology at the University of Massachusetts Memorial Medical Center.
Communication with doctors is critical to early, accurate colorectal cancer diagnosis
Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S., but if diagnosed early, patients have a five-year survival rate of 91 percent. In a study recently published in the journalPatient Education and Counseling, Laura A. Siminoff, Ph.D., and a team of researchers conducted in-depth interviews with 242 patients diagnosed with CRC in the six months preceding the study.
Grant supports development of novel brain cancer treatment at VCU Massey
With the support of grant funding from the National Institutes of Health (NIH), researchers at Virginia Commonwealth University Massey Cancer Center are hard at work investigating a new "synthetically lethal" strategy for treating glioblastoma multiforme (GBM), the most common and deadly form of brain cancer.
Discoveries in mitochondria open new field of cancer research
Researchers at Virginia Commonwealth University Massey Cancer Center have revealed novel mechanisms in mitochondria that have implications for cancer as well as many other age-related diseases such as Parkinson’s disease, heart disease and hypertension. This discovery has pioneered the formation of a whole new field within epigenetics research ripe with possibilities of developing future gene therapies to treat cancer and age-associated diseases.
Researcher awarded NCI grant to investigate novel anti-tumor vaccine
Xiang-Yang (Shawn) Wang, Ph.D., was recently awarded a $310,213 grant from the National Cancer Institute to support his research involving large stress proteins (LSPs) in immune regulation and cancer immunotherapy. Wang is a VCU Massey Cancer Center Harrison Scholar, member of the VCU Institute of Molecular Medicine and associate professor of human and molecular genetics at the VCU School of Medicine.